Hormone therapy of metastasizing breast cancer with tamoxifen
Köhler, A.; Noss, W.; Dobberstein, N.; Stoltmann, R.; Pohl, J.
Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(1): 6-9
1986
ISSN/ISBN: 0044-2542 PMID: 3953121 Document Number: 271307
Out of 79 patients with metastasized carcinoma of the breast in 33% (6 patients) a response to a Tamoxifen therapy could be observed. For complete remissions the remission periods were 12.3 months, for partial remissions 9.9 months and in the group of constant findings 4.9 months. Preferably metastases of the soft parts respond to the therapy. The side effects are very insignificant. The indications for the tamoxifen therapy are represented as well as the importance of the determination of hormone receptors.